Synapse-associated protein-97 mediates α-secretase ADAM10 trafficking and promotes its activity

被引:157
作者
Marcello, Elena
Gardoni, Fabrizio
Mauceri, Daniela
Romorini, Stefano
Jeromin, Andreas
Epis, Roberta
Borroni, Barbara
Cattabeni, Flaminio
Sala, Carlo
Padovani, Alessandro
Di Luca, Monica
机构
[1] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy
[2] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy
[3] Univ Milan, CNR, Inst Neurosci Cellular & Mol Pharmacol, Dept Pharmacol, I-20129 Milan, Italy
[4] Univ Texas, Ctr Learning & Mem, Austin, TX 78712 USA
[5] Univ Brescia, Dept Neurol Sci, I-25125 Brescia, Italy
关键词
ADAM10; SAP97; APP; glutamatergic synapse; Alzheimer's disease; trafficking;
D O I
10.1523/JNEUROSCI.3439-06.2007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is a chronic neurodegenerative disorder caused by a combination of events impairing normal neuronal function. Here we found a molecular bridge between key elements of primary and secondary pathogenic events in AD, namely the elements of the amyloid cascade and synaptic dysfunction associated with the glutamatergic system. In fact, we report that synapse-associated protein-97 (SAP97), a protein involved in dynamic trafficking of proteins to the excitatory synapse, is responsible for driving ADAM10 (a disintegrin and metalloproteinase 10, the most accredited candidate for alpha-secretase) to the postsynaptic membrane, by a direct interaction through its Src homology 3 domain. NMDA receptor activation mediates this event and positively modulates alpha-secretase activity. Furthermore, perturbing ADAM10/SAP97 association in vivo by cell-permeable peptides impairs ADAM10 localization in postsynaptic membranes and consequently decreases the physiological amyloid precursor protein (APP) metabolism. Our findings indicate that glutamatergic synapse activation through NMDA receptor promotes the non-amyloidogenic APP cleavage, strengthening the correlation between APP metabolism and synaptic plasticity.
引用
收藏
页码:1682 / 1691
页数:10
相关论文
共 53 条
[1]   Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions [J].
Aarts, M ;
Liu, YT ;
Liu, LD ;
Besshoh, S ;
Arundine, M ;
Gurd, JW ;
Wang, YT ;
Salter, MW ;
Tymianski, M .
SCIENCE, 2002, 298 (5594) :846-850
[2]   Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease [J].
Adlard, PA ;
Perreau, VM ;
Pop, V ;
Cotman, CW .
JOURNAL OF NEUROSCIENCE, 2005, 25 (17) :4217-4221
[3]   The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3 [J].
Amour, A ;
Knight, CG ;
Webster, A ;
Slocombe, PM ;
Stephens, PE ;
Knäuper, V ;
Docherty, AJP ;
Murphy, G .
FEBS LETTERS, 2000, 473 (03) :275-279
[4]  
BertoniFreddari C, 1996, ANAL QUANT CYTOL, V18, P209
[5]   Molecular pathways to neurodegeneration [J].
Bossy-Wetzel, E ;
Schwarzenbacher, R ;
Lipton, SA .
NATURE MEDICINE, 2004, 10 (07) :S2-S9
[6]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[7]   Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor [J].
Buxbaum, JD ;
Liu, KN ;
Luo, YX ;
Slack, JL ;
Stocking, KL ;
Peschon, JJ ;
Johnson, RS ;
Castner, BJ ;
Cerretti, DP ;
Black, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :27765-27767
[8]  
Caputi A, 1997, J NEUROCHEM, V68, P2523
[9]   Natural oligomers of the amyloid-protein specifically disrupt cognitive function [J].
Cleary, JP ;
Walsh, DM ;
Hofmeister, JJ ;
Shankar, GM ;
Kuskowski, MA ;
Selkoe, DJ ;
Ashe, KH .
NATURE NEUROSCIENCE, 2005, 8 (01) :79-84
[10]   Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein [J].
De Strooper, B ;
Saftig, P ;
Craessaerts, K ;
Vanderstichele, H ;
Guhde, G ;
Annaert, W ;
Von Figura, K ;
Van Leuven, F .
NATURE, 1998, 391 (6665) :387-390